Search research articles
Contact Us
Filters
Showing results (11-20 of 33) with videos related to
Page
of 4
Sort By:
Molecular Cancer Research : MCR
|
August 9, 2017
Comprehensive Genomic Profiling of Metastatic Squamous Cell Carcinoma of the Anal Canal
Van Morris, Xiayu Rao, Curtis Pickering, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 2, 2022
Omics analyses of a somatic <i>Trp53</i> breast cancer model identify cooperating driver events activating PI3K/AKT/mTOR signaling
Xiaojie Yu, Yun Zhang, Shunbin Xiong, et al.
Molecular Cancer Therapeutics
|
October 5, 2023
Neutrophil Elastase Remodels Mammary Tumors to Facilitate Lung Metastasis
Amriti R Lulla, Said Akli, Cansu Karakas, et al.
Cancer
|
August 16, 2020
Functionally impactful TP53 mutations are associated with increased risk of extranodal extension in clinically advanced oral squamous cell carcinoma
Frederico O Gleber-Netto, David Neskey, Ana Flávia de Mattos Costa, et al.
Molecular Cancer
|
February 15, 2025
Single-cell RNA sequencing identifies molecular biomarkers predicting late progression to CDK4/6 inhibition in patients with HR+/HER2- metastatic breast cancer
Linjie Luo, Peng Yang, Sofia Mastoraki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 14, 2018
High-Risk <i>TP53</i> Mutations Are Associated with Extranodal Extension in Oral Cavity Squamous Cell Carcinoma
Vlad C Sandulache, Chieko Michikawa, Pranav Kataria, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 17, 2019
PDK1 Mediates <i>NOTCH1</i>-Mutated Head and Neck Squamous Carcinoma Vulnerability to Therapeutic PI3K/mTOR Inhibition
Vaishnavi Sambandam, Mitchell J Frederick, Li Shen, et al.
Oncogenesis
|
May 15, 2021
LMW cyclin E and its novel catalytic partner CDK5 are therapeutic targets and prognostic biomarkers in salivary gland cancers
Amriti R Lulla, Said Akli, Cansu Karakas, et al.
Oncotarget
|
November 22, 2017
Genomic characterization of human papillomavirus-positive and -negative human squamous cell cancer cell lines
Nene N Kalu, Tuhina Mazumdar, Shaohua Peng, et al.
Cancer Research
|
June 29, 2023
Abemaciclib Is Effective in Palbociclib-Resistant Hormone Receptor-Positive Metastatic Breast Cancers
Juliana Navarro-Yepes, Nicole M Kettner, Xiayu Rao, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 33) with videos related to
Sort By:
Page
of 4
Molecular Cancer Research : MCR
|
August 9, 2017
Comprehensive Genomic Profiling of Metastatic Squamous Cell Carcinoma of the Anal Canal
Van Morris, Xiayu Rao, Curtis Pickering, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 2, 2022
Omics analyses of a somatic <i>Trp53</i> breast cancer model identify cooperating driver events activating PI3K/AKT/mTOR signaling
Xiaojie Yu, Yun Zhang, Shunbin Xiong, et al.
Molecular Cancer Therapeutics
|
October 5, 2023
Neutrophil Elastase Remodels Mammary Tumors to Facilitate Lung Metastasis
Amriti R Lulla, Said Akli, Cansu Karakas, et al.
Cancer
|
August 16, 2020
Functionally impactful TP53 mutations are associated with increased risk of extranodal extension in clinically advanced oral squamous cell carcinoma
Frederico O Gleber-Netto, David Neskey, Ana Flávia de Mattos Costa, et al.
Molecular Cancer
|
February 15, 2025
Single-cell RNA sequencing identifies molecular biomarkers predicting late progression to CDK4/6 inhibition in patients with HR+/HER2- metastatic breast cancer
Linjie Luo, Peng Yang, Sofia Mastoraki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 14, 2018
High-Risk <i>TP53</i> Mutations Are Associated with Extranodal Extension in Oral Cavity Squamous Cell Carcinoma
Vlad C Sandulache, Chieko Michikawa, Pranav Kataria, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 17, 2019
PDK1 Mediates <i>NOTCH1</i>-Mutated Head and Neck Squamous Carcinoma Vulnerability to Therapeutic PI3K/mTOR Inhibition
Vaishnavi Sambandam, Mitchell J Frederick, Li Shen, et al.
Oncogenesis
|
May 15, 2021
LMW cyclin E and its novel catalytic partner CDK5 are therapeutic targets and prognostic biomarkers in salivary gland cancers
Amriti R Lulla, Said Akli, Cansu Karakas, et al.
Oncotarget
|
November 22, 2017
Genomic characterization of human papillomavirus-positive and -negative human squamous cell cancer cell lines
Nene N Kalu, Tuhina Mazumdar, Shaohua Peng, et al.
Cancer Research
|
June 29, 2023
Abemaciclib Is Effective in Palbociclib-Resistant Hormone Receptor-Positive Metastatic Breast Cancers
Juliana Navarro-Yepes, Nicole M Kettner, Xiayu Rao, et al.
Page
of 4